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Poliovirus intrahost evolution is required to
overcome tissue-specific innate immune responses
Yinghong Xiao1, Patrick Timothy Dolan1,2, Elizabeth Faul Goldstein1, Min Li1, Mikhail Farkov3, Leonid Brodsky3
& Raul Andino1
RNA viruses, such as poliovirus, have a great evolutionary capacity, allowing them to quickly
adapt and overcome challenges encountered during infection. Here we show that poliovirus
infection in immune-competent mice requires adaptation to tissue-specific innate immune
microenvironments. The ability of the virus to establish robust infection and virulence
correlates with its evolutionary capacity. We further identify a region in the multi-functional
poliovirus protein 2B as a hotspot for the accumulation of minor alleles that facilitate a more
effective suppression of the interferon response. We propose that population
genetic dynamics enables poliovirus spread between tissues through optimization of the
genetic composition of low frequency variants, which together cooperate to circumvent
tissue-specific challenges. Thus, intrahost virus evolution determines pathogenesis, allowing
a dynamic regulation of viral functions required to overcome barriers to infection.
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RNA viruses exist as dynamic and diverse populations thatrapidly adapt to selective pressures. Viral genetic structureis shaped by constant mutation and selection1, 2. Diversity,
which powers evolution, accumulates by misincorporation of
nucleotides during RNA synthesis. However, diversity comes at a
cost, since most mutations are deleterious. As lineages carrying
beneficial mutations arise in the population, they accumulate
detrimental mutations which prevent them from being effectively
selected. This increasing mutational load slows the rate of
evolution, an effect known as “Muller’s Ratchet”. Competition
between adaptive lineages, or “clonal interference’, also slows the
rate of evolution3–8. Without a mechanism to break the linkage
between detrimental and beneficial mutations9–11 and avoid
competition between beneficial mutations3–8, the rate of
population evolution is greatly reduced3–11. Recombination
accelerates the rate of evolution by mitigating the mutational load
carried by adaptive lineages, relieving competition by purging
deleterious mutations, and combining beneficial mutations into
the same genome4, 6. Effective recombination is critical to rapid
adaptation to dynamic selective environments.
The immune system represents a major barrier to viral infec-
tion. Innate immune responses exert strong selective pressures as
the virus spreads throughout the organism. Infection sets forth a
cascade of intracellular and extracellular innate immune signals
that establish an antiviral state in the host12–20. Virus replication
and intrahost spread depends on a virus’ ability to overcome early
innate immune responses14–16. The type I interferon (IFN)
response, for example, has been shown to control poliovirus
tissue tropism in mice12, 13. As evidence of the strong selective
pressure that innate immunity places on viral populations, viruses
have evolved many mechanisms to directly counteract these
signals and responses17–20.
Although the fitness of a virus, its ability to infect, propagate
and spread to a new host, has been linked to the genetic diversity
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Fig. 1 RNA viral evolution capacity is required to overcome the type I interferon (IFN) response. a The structure of RNA dependent RNA polymerase
(RdRp) of poliovirus. G64S (G) confers higher replication fidelity and D79H (D) reduces recombination rate24–26. b Mutation rates associated of wild type
(WT) and G64S/D79H (GD) poliovirus. Mutation rates are shown for G to A, C to U and U to A substitutions, based upon the frequency of lethal
mutations (P< 0.05, seven passages, n= 7, mean± s.d.). c Recombination rates for WT and GD poliovirus. For additional details see Supplementary Fig. 1.
d Percentage survival of Tg21 mice or IFNAR−/− mice (n= 10 for each cohort) infected with virus by I.P. inoculation route. Mice were inoculated with
108 plaque-forming units (PFU) per Tg21 mouse or with 104 PFU per IFNAR−/− mouse (n= 10 for each cohort). e 50% lethal dose (LD50) by
intra-peritoneal (I.P.) and intra-muscular (I.M.) route (n= 10 for each cohort)
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of the virus population1, 2, 21–24, the mechanistic links between
diversity, adaptation, pathogenesis and in vivo selective pressures
are not well understood. Given that innate immune responses
represent the first line of defense against viral infection and
certain immune effectors, such as IFN, elicit tissue-specific
responses12, 13, we hypothesized that the virus’ ability to
establish infection may be tied to its capacity to rapidly adapt to
tissue-specific innate immune environments. In this study, we use
poliovirus as a model to examine these questions and to establish
whether and how a virus’ ability to adapt facilitates viral spread
and pathogenicity.
Results
G64S/D79H(GD) confers lower mutation and recombination
rates. To examine the role of mutation and recombination
in vivo, we employed a poliovirus (PV) variant, G64S/D79H
(GD), that carries two mutations within the RNA-dependent
RNA polymerase (RdRp), 3D, which alter mutation (G64S)24, 25
and recombination (D79H) rates (Fig. 1a–c)26. Using a highly
accurate deep-sequencing approach, CirSeq27, 28, which enables
detection of very low frequency variants, we examined mutation
rates of GD in HeLa cells. Our measurements confirmed that
GD displays a 3-fold lower mutation rate compared with
wild type (WT) (Fig. 1b, P< 0.05, n= 7). Using a recently
developed cell-based recombination assay26, 29, we confirmed that
recombination rate was reduced 10-fold in GD compared to WT
(Fig. 1c and Supplementary Fig. 1).
Adaptive capacity increases PV’s ability to overcome the Type I
IFN response. With a higher mutation rate and
efficient recombination, WT populations can take maximal
advantage of rare beneficial mutations without being
overwhelmed by an increasing load of deleterious mutations
(Muller’s ratchet) or impeded by clonal interference3–8. GD
carries defects in these two important evolutionary determinants.
As such, we expect GD to be substantially limited in its capacity
to rapidly adapt to selective pressures. To examine the hypothesis
that rapid viral adaptation is required to overcome in vivo
selective pressures, such as innate immune responses, we
compared the outcome of infection with WT and GD viruses in a
murine model. Immune-competent mice (Tg21) or mice defective
in type I IFN receptor (IFNAR−/−), were infected with GD
or WT populations by intraperitoneal (I.P.) or intramuscular
(I.M.) routes (Fig. 1d and Supplementary Fig. 2). GD was
significantly attenuated compared to WT in Tg21 mice (Log-rank
(Mantel–Cox) test, P< 0.0001, n= 10, Fig. 1d and Supplementary
Fig. 2, left panel). Irrespective of the route of inoculation, the
50% lethal dose (LD50) of GD virus is approximately 200-fold
higher than WT virus in Tg21 mice (n= 10) (Fig. 1e and
Supplementary Fig. 2). In the immune-compromised IFNAR−/−
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Fig. 2 The tissue distribution of the virus strains in Tg21 and IFNAR−/− mice. a Experimental schematic for determining the virus titer in individual tissues.
b, c Virus titers in tissue collected from WT or GD infected mice by I.P. inoculation route. Tg21 (106 PFU per mouse) or IFNAR−/− (104 PFU per mouse).
Data are shown as logarithm, mean± s.d., PFU per gram of tissue (n= 5, the number of mice is five for each time point and each group). Student’s t-test,
n.s. indicates P> 0.05, *P≤ 0.05, **P≤ 0.01, ***P≤ 0.001. Limited detection level is 20 PFU per gram tissue
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Fig. 3 Tissue-specific transcriptional responses induced by poliovirus infection. a Line plot showing the gene expression profiles for 341 genes in liver and
kidney from Tg21 mice infected with WT poliovirus at 107 PFU by I.P. inoculation route. (n= 3, the number of mice is three for each time point and each
group). Gene expression profiles across all experimental conditions were clustered to yield 5 clusters (Methods). Each gene’s trajectory is shaded by its
cluster and the mean trajectory for each cluster is shown as a thick line. b Multidimensional scaling plot of the transcriptional response trajectories in liver
and kidney. Each point represents the mean transcriptional response of three mice. Shaded ovals are drawn to emphasize the distinct trajectories of liver
and kidney responses in infected mice. c Scatter plot showing the relative induction of genes in liver and kidney at 1 (left) and 3 (right) days postinfection.
Genes are colored by cluster. d A multidimensional scaling plot of the coregulatory relationships between genes. Genes are arranged by the similarity of
their expression response (determined by Euclidian distance) and colored by cluster. e Known innate immune and antiviral genes group together in clusters
1 and 5
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mice, GD was pathogenic; suggesting that a major determinant
for the observed GD attenuated phenotype in immune-competent
mice is its inability to overcome type I IFN responses (Fig. 1d, n
= 10, and Supplementary Fig. 2, right panel). Notably, even
in IFNAR−/− mice, the virulence of GD is slightly reduced,
as mouse survival is extended by a few days compared to
WT. Thus, although type I IFN response is one major factor
determining GD attenuation, additional selective pressures
are likely to determine the dynamics of infection in immune-
competent mice.
To test virus replication kinetics, we compared the growth of
GD virus to WT in cultured cells. GD virus production and RNA
replication rate was not significantly different from that of WT in
L20B, a murine fibroblast cell line (Supplementary Fig. 3 and
Methods). Additionally, we performed a more sensitive competi-
tion assay to calculate the viral fitness (Supplementary Fig. 3),
where L20B cells were infected with GD and WT at a 1 to 1 ratio.
Following four passages, GD and WT maintained the 1 to 1 ratio
(Supplementary Fig. 3C). Thus, while GD replication fitness is
similar to WT in murine cells in culture, the low diversity GD
virus is unable to effectively replicate and spread in immune-
competent mice. Together these observations are consistent with
the idea that rapid adaptation is required to overcome the diverse
challenges encountered in vivo, such as innate immune responses.
To further test this idea, we examined the tissue-specific
replication levels of the viruses in Tg21 and IFNAR−/−
mice infected with GD or WT virus (Fig. 2). WT virus inoculated
to immune-competent mice was readily detected in
spleen, kidney, small intestine, muscle, spinal cord and brain
of immune-competent mice (Fig. 2b). GD virus was also
detected in spleen, kidney, small intestine, muscle, albeit to
lower levels, but remained undetectable in spinal cord and
brain in immune-competent mice, even at 6 days postinfection
(Fig. 2b). In contrast, in IFNAR−/− mice, WT and GD
virus populations replicated with nearly identical kinetics in
spleen and kidney, reaching similar titers and quickly spreading
to the central nervous system (CNS) (Fig. 2c). If delivered
intra-cranially, GD can replicate in the CNS of immune-
competent Tg21 mice (Supplementary Fig. 4), suggesting
that the attenuated phenotype of GD in Tg21 mice is not
due to the inability of GD to replicate in CNS, but rather to
overcome the IFN-induced barriers to establish infection in
the CNS. We thus conclude that WT virus, with full adaptive
capacity, is able to overcome these innate immune challenges
more effectively, while GD, with a limited capacity to adapt,
cannot and is thus restricted to replicate at lower levels in fewer
tissues.
Tissue-specific responses induced during PV infection. Cellular
environments and antiviral responses vary between tissues12. We
hypothesized that these variable environments exert distinct evo-
lutionary constraints on infecting viral populations and, thus, the
virus population needs to adapt to the specific environment to
replicate efficiently. To quantify the response to viral infection in
individual tissue, we performed genome-wide transcriptome ana-
lysis using RNA-Seq (Methods). We focused on liver and kidney
because both WT and GD viruses replicate in these tissues,
allowing to link adaptation capacity and tissue specific responses to
infection. Livers and kidneys were collected from immune-
competent Tg21 mice (n= 3 for each time point) after infection
with 106 or 107 PFU of WT virus, or 108 PFU of GD virus,
administered by I.P. route at 1 and 3 days postinfection. Genes
which were altered in expression by greater than 4-fold in response
to infection (with a false discovery rate, q< 0.01) at day 1 or day 3
postinfection in either tissue were used for clustering (N= 341) to
identify the genes with similar transcriptional profiles. As expected,
the infected mice show marked alterations in gene expression in
both liver and kidney when compared to mock-infected mice
(Fig. 3). Genes in two clusters show increased expression level at
day one postinfection, clusters 1 and 5 (Fig. 3a, c). Cluster 5 shows
a largely kidney-specific induction in response to infection. Con-
versely, the expression of the genes in Cluster 2 were down-
regulated in response to infection in liver (Fig. 3a, c). To visualize
the global differences in the dynamic transcriptional response to
infection in kidney and liver during infection, we used multi-
dimensional scaling to compare global gene expression in each
sequenced tissue (Fig. 3b). This visualization emphasizes the tissue-
specific responses to poliovirus infection in liver and kidney and
highlights the dynamics of the host responses. Gene expression
responses at day 1 show the greatest difference compared to mock
and these responses begin to recover to control gene expression
levels by day 3.
Importantly, the transcriptional responses to infection were
very similar between virus genotypes, indicating that, at the titers
used in these experiments, GD and WT encounter similar levels
of tissue specific factors and, as a result, similar levels of selection
as defined by these factors (Fig. 3c and Supplementary Fig. 5).
This is consistent with the observation that similar levels of virus
were detected at 1 day postinfection with 107 PFU of WT virus
and 108 PFU GD per mouse in the spleen and kidney of the
infected mice, suggesting that, despite different initial titers, these
viral genotypes elicit very comparable responses to infection
(Supplementary Fig. 5 and 6).
We next examined the pattern of the expression for known
immune genes and bona fide anti-poliovirus genes30. These genes
show striking similarity in their transcriptional responses,
grouping together in clusters 1 and 5 (Fig. 3d,e), emphasizing
their tight co-regulation during infection. Most of these genes,
including IRF7, MX1, MX2, and a number of OAS paralogs fell
into the highly upregulated cluster 1, which shows greater
upregulation in kidney, while others, including ADAR, TRIM, and
CCL9, fall in cluster 5, which shows higher kidney-specific
expression (Fig. 3c). It is likely that these differences in the levels
of the induction of antiviral genes result in distinct selective
environments in the kidney and liver.
The virus population structure is determined by the tissue-
specific environment. Given that global transcriptional responses to
infection are distinct and specific to a given tissue type (Fig. 3), we
next examined the hypothesis that these unique antiviral micro-
environments drive tissue-specific intrahost adaptation. Tg21 mice
were infected with WT and GD and viral populations were isolated
from spleen, kidney and liver and analyzed by deep sequencing to
assess the tissue-specific diversity and genetic structure. WT popu-
lations isolated from the same infected tissues showed strikingly
similar patterns of mutation composition across the genome
(Fig. 4a–c). In contrast, GD populations isolated from infected tissues
showed similar overall diversity, however, the pattern of diversity
differed fromWT populations. (Fig. 4a, b). For example, liver-derived
WT populations accumulated mutations at sites in the 5′ UTR and in
the 2C coding region of the PV genome and the majority of muta-
tions in spleen-derived populations accumulated in the 3Dpol pro-
tein. In contrast, these mutations were not observed in the GD
populations. All three populations exhibited similar patterns in the
VP3 coding region (Fig. 4a).
We next used multidimensional scaling to visualize the
pairwise genetic distances between the sequenced viral popula-
tions isolated from each tissue. Spleen-, liver- and kidney-derived
WT populations formed distinct genotypic clusters, indicating
that WT populations rapidly establish tissue-specific population
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structures in vivo (Fig. 4a, b). Importantly, the WT populations
isolated from different mice clustered together by tissue,
indicating that these population structures are established
reproducibly during infection in independent, isogenic hosts
(Fig. 4c). In contrast, GD virus isolated from all tissues remained
nearly identical to the parental genotype, consistent with the idea
that GD reduced evolutionary capacity precludes the virus to
evolve in a given environment (Fig. 4a–c).
GD is highly attenuated in the presence of an intact immune
response, but this attenuation is largely relaxed in IFNAR−/−
mice. Our RNA-Seq data indicate that the response to infection,
including innate antiviral responses, vary between tissues.
Population sequencing reveals that WT populations establish
specific population structures in vivo, presumably adapting to
tissue-specific selection. On the contrary, while GD elicits a
similar antiviral response in infected tissues it cannot establish a
successful infection in certain tissues and is cleared from tissue
more rapidly than WT (Fig. 2). Taken together, these data suggest
a model for the attenuation observed in GD infected mice
(Fig. 4d). In WT infection, mutation and recombination together
facilitate the establishment of tissue-specific population diversity.
However, GD, with defects in mutation and recombination, is less
effective in establishing tissue-specific population compositions
and therefore cannot overcome the microenvironment of
antiviral selection (Fig. 4d). This raises the question of how
specific patterns in the population composition, consisting of
low frequency alleles, can counteract antiviral defenses, and
contribute to overcoming barriers to infection.
Fig. 5 The 2B coding region of the poliovirus genome is a hotspot for the accumulation of mutations following cell culture adaptation. a High-density
genetic screen procedure to identify adaptive mutations on cell culture conditions. WT, GD, or WT were passaged in HeLa cells or HeLa cells pre-treated
with interferon β (IFN β). Using circular resequencing (CirSeq), the mutation composition, allele frequency distribution, and fitness of specific alleles
were determined. b Scatter plot showing the position and fitness of identified adaptive mutations. Adaptive alleles with fitness values >2 standard
deviations (s.d.s) above neutrality are shown. Alleles with fitness> 25 s.d.s above neutrality are labeled. The details of the specific mutations labeled in the
plot are shown in Supplementary Table 1. The 2B coding region of the genome is shaded grey. c Allele frequency spectrums for 4 independently passaged
of poliovirus (PV) populations. Alleles are ranked by frequency and plotted to show the relative diversity of passaged populations. All populations
shown are from passage 6 of parallel passage experiments. d Interferon (IFN) sensitivity assay for specific 2B mutations identified in the passage screen.
One-tailed Student’s t-test. *P≤ 0.05, **P≤ 0.01, n= 3. Data were presented as logarithm(mean± s.d.), PFU per ml. n= 3, three replicates for each time,
for each viral strain. e,f Comparison of immune signaling in MG63 cells infected by WT or 2B mutants at m.o.i=20. e Supernatant was collected at the
indicated times to measure IFN β induction by ELISA. IFN β level< 2.3 pg /ml is undetectable. f mRNA expression level of IL6, IL8, RIG-I, TNFα measured
by qRT-PCR at postinfected 5 h by 2B mutants and WT. Data shows mean± s.d., * P< 0.05, ** P< 0.01, n= 3, Student’s t-test. g Growth kinetics of
poliovirus carrying 2B mutations identified in HeLa cells. Viruses replication was examined for 2B mutants and WT by one-step growth curves in HeLa
cells (m.o.i=10). (Data are shown as mean± s.d., ***P< 0.0001, n= 3, three replicates for each time, for each viral strain, Student’s t-test). h. SEAP
reporter assay to assess the ability of 2B mutants to inhibit protein secretion activity. One-tailed Student’s t-test. *P≤ 0.05, n= 3, three replicates for
each time, for each viral strain
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The 2B coding region is a hotspot for the accumulation of
adaptive mutations. In vivo selective environments are highly
complex. A given tissue is constituted by multiple cell types.
Physicochemical environments, macromolecular compositions,
and antiviral responses all vary between tissues. In addition, the
dynamics of populations during intrahost spread, characterized
by small population sizes and repeated bottlenecking are not
well defined, cannot be controlled, and may result in stochastic
processes such as genetic drift, affecting the mutation composi-
tion of the population. Thus, to better understand the
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mechanisms and the population dynamics contributing to viral
fitness and adaptation, we turned to a simple and well controlled,
cell culture system, which circumvents many of the confounding
factors associated with infection in animals.
We carried out seven serial passages in HeLa cells, using
WT and GD viral populations at a multiplicity of infection (m.o.i)
of 0.1, limiting each passage to a single replication cycle 8 h
(schematized in Fig. 5a and Methods). The mutation composition
of each population was analyzed by an ultra-accurate next-
generation sequencing technique, CirSeq, which allowed us to
identify very low-frequency mutations27, 28.
Similar to the tissue-specific patterns of diversity observed
in vivo, WT populations accumulated reproducible cohorts of
high fitness mutations. Adaptive mutations were distributed
along the viral genome, strikingly, a cluster of mutations
accumulated within the 2B protein coding region in multiple
WT passage experiments (Fig. 5b and Supplementary Table 1).
Protein 2B is a small, multifunctional membrane protein
consisting of only 97 amino acids, which may function both as
an independent protein and as an un-cleaved 2BC precursor31. In
contrast, GD passaged in parallel demonstrated a reduced
accumulation of adaptive mutations at any particular region in
the genome (Fig. 5b and Supplementary Table 1), which is similar
to our observations in vivo.
These observations are consistent with the idea that GD is
defective in its ability to adapt, and thus cannot accumulate
adaptive mutations to overcome tissue-specific challenges
(Fig. 4b). Examining the allele frequency spectrum of the
passaged populations provides an alternative view of the effects
of selection, mutation and recombination on the populations
(Fig. 5c). WT populations (Fig. 5c, WT and PV in black) show
remarkably similar distributions of allele frequency, while
the number of low frequency alleles is higher in the passaged
GD population, suggesting that GD population is defective in
accumulation and selection of mutations. This increase in low
frequency mutations but apparent lack of adaptive alleles (Fig. 2b)
is likely due to the “Muller’s ratchet” effect on the population.
As type I IFN responses appear to be a major obstacle for GD
in establishing a robust infection in vivo, we next examined the
virus adaptation to an IFN-activated environment. WT virus was
serially passaged in HeLa cells pre-treated with IFNβ or untreated
control Hela cells (Fig. 5a). Strikingly, several 2B mutations
sharply increase their fitness value under IFN pre-treatment
condition (Fig. 5b). Fewer adaptive alleles were identified under
IFN treatment, and the population diversity of these populations
was more limited (Fig. 5c), consistent with stronger purifying
selection due to IFN-induced immune responses.
The information obtained from infected animals (Figs. 1–4)
suggests that virus adaptation is required to overcome
innate immune barriers and thus establish a successful infection
(Figs. 3 and 4). Our in vitro experiments identified a hotspot in
the 2B protein region for adaptive alleles that appear to be
selected when cells are stimulated with IFNβ. Importantly, these
mutations are not selected in GD, consistent with the idea that
GD exhibits a reduced capacity to evolve in response to selection.
To directly test whether the mutations observed in 2B counteract
innate immune signaling, we engineered six of the high fitness
2B mutations into the PV genome. HeLa cells, pretreated with
500 IU/ml IFN alpha (IFNα) for 24 h, were infected with 2B
variants or WT virus. Three of 2B mutants: 2B I2V (amino acid
1032 Ile->Val, nucleotide position, 3836–3838 ATC to GTG), 2B
I6V (amino acid 1036 Ile->Val, nucleotide position, 3848 A->G)
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Fig. 6 Adaptive 2B mutants increased virus replication and pathogenesis immune-competent mice. a, b The adaptive 2B mutants induce less IFN response
in primary murine embryo fibroblast cells (MEFs). aMEFs were infected with WT and 2B mutants at m.o.i=0.1. supernatant was collected to measure IFNβ
by ELISA at 72 h postinfection. RNA copy number of poliovirus genome was measured by qRT-PCR on MEFs at postinfection 72 h. b mRNA expression
level of IRF7 and ISG56 was measured by qRT-PCR on MEFs at postinfection 72 h (n= 3, three replicates for each time, for each viral strain. Student’s
t-test). n.s. indicates P> 0.05; *P≤ 0.05, **P≤ 0.01. c Virus tissue distribution. Viral titers in kidney, muscle and brain of Tg21 mice inoculated with 106 PFU
of WT, 2B I2V, 2B I6V, and 2B I6M administered I.P. route. Data were presented as logarithm(mean± s.d.), PFU per ml. n= 4, the number of the mice is
four per time point per viral strain. Limited detection level is 20 PFU per gram tissue. d Survival curve of Tg21 mice Tg21 mice were injected with 107 PFU
WT, 2B I2V, 2B I6V, or 2B I6M administered by I.P. route. (n= 10, the number of the mice is ten per group)
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-017-00354-5
8 NATURE COMMUNICATIONS |8:  375 |DOI: 10.1038/s41467-017-00354-5 |www.nature.com/naturecommunications
and 2B I6M (amino acid 1036 Ile->Met, nucleotide position, 3850
A->G) yield at least 100 times more virus than WT in IFNα
pretreated condition (Fig. 5d) (Student’s t-test, p< 0.05, n= 3).
These results suggest that alleles identified in 2B overcome
restrictions on replication imposed by the effects of IFN response.
Inhibition of the antiviral IFN system by 2B variants. To
further study the effect of 2B variants on the IFN signaling, we
initially compared IFN β production following WT or the 2B
mutants infection. MG63 cells32 infected with WT produced
readily detectable levels of IFNβ at 5 and 7.5 h postinfection
(Fig. 5e). In contrast, infection with 2B mutants did not induce
detectable levels (<2.3 pg per ml) of IFNβ (Fig. 5e). Furthermore,
genes, RIG-I, TNFα, Interleukin 6 (IL6), and Interleukin 8 (IL8)
were all expressed at significantly lower levels in cells infected
with 2B mutants compared to WT virus (Fig. 5f) (Student’s t-test,
p< 0.001, n= 3).
Together, these experiments indicate that mutations accumu-
lating within 2B counteract innate immune responses in
cell culture system. The viral protein 2B has been implicated
in poliovirus RNA synthesis, inhibits protein secretion and
membrane permeability33, 34. It is possible that the increase in
IFN suppression is the consequence of an increase of virus
replication or a direct effect on IFN secretion. To examine if the
2B mutants enhance viral replication, we examine virus
production by performing one-step growth curve. A significant
increase in viral replication rate was observed for 2B I2V, 2B I6V,
and 2B I6M compared to WT at 6 h postinfection. However, by 8
h, 2B variants and WT are produced at similar levels (Fig. 5g).
Next we examined the effect of 2B mutations on protein
secretion. We transfected an EMCV-IRES-driven secreted
alkaline phosphatase (SEAP) reporter into COS7 cells33, 35
(Fig. 5h), then infected COS7 cells with 2B mutants or WT
virus. We measured SEAP activity accumulating in the media of
infected cells between 0 and 2, 2 and 4, and 4 and 6 h
postinfection. The 2B mutants inhibited protein secretion to
a greater extent than WT (Fig. 5h) (One-tailed Student’s t-test,
n= 3, p< 0.05), indicating that the mutations in 2B may
modulate its effect on cellular protein secretion.
Effect of 2B mutants on viral replication and pathogenesis in
mice. We next tested if the adaptive 2B mutants, identified in
HeLa cells, also counteract the type I IFN response in primary
murine embryo fibroblast cells (MEFs) isolated from immune-
competent Tg21 mice. MEFs were infected with 2B mutants or
WT virus and the level of secreted IFNβ was measured at 72 h
postinfection. Although the same levels of viral RNA were
detected at 72 h postinfection, the 2B mutants induced
significantly lower levels of the IFNβ compared to WT in media
(Fig. 6a, One-tailed Student’s t-test, n= 3, p< 0.05). Additionally,
the mRNA levels of interferon regulatory factor 7 (IRF7) and
interferon stimulate gene 56 (ISG56) were both lower in MEFs
infected with 2B mutants than WT (Fig. 6b). If these 2B mutants
have a higher capacity to suppress innate immune responses
in vivo, it would be expected that these mutants could replicate
more effectively in infected animals. Indeed, in innate immune-
competent Tg21 mice, 2B mutants (I2V, I6V, and I6M) exhibit
increased replication levels in muscle, kidney, and brain
compared to WT (Fig. 6c) and increased virulence in infected
animals (Fig. 6d).
Taken together, these results suggest that the high fitness alleles
that accumulated in 2B during adaptation to IFN pretreatment in
cell culture increase the rate of replication, inhibit protein
secretion and counteract IFN responses. This suggests that
2B regulates virulence in vivo by modulating IFN responses
(Figs. 5 and 6). Although the mutations identified in cell culture
differ from those in the organ-resident virus populations observed
in vivo, it is consistent with the concept that the ability to rapidly
adapt is central to the fitness of viral populations. Facing variable
selective environments, the adaptive capacity of viral populations
enables rapidly access to evolutionary solutions.
Discussion
The selective environment encountered by the viral populations
in vivo is dynamic and heterogeneous. Here we report that,
during WT poliovirus infection, this heterogeneous selective
environment drives the development of tissue-specific patterns of
diversity in the organ-resident virus populations. Importantly,
none of the adaptive alleles are fixed in the population. As a
result, the virus maintains the master consensus sequence. In
contrast to classical evolutionary theory, where beneficial alleles
compete to fix in the population, we propose that the population
master sequence has been positioned in sequence space to
optimize its access to distinct genetic neighborhoods. These
functional subpopulations then cooperate to overcome tissue-type
and cell-type specific selective pressures (Fig. 4d)36. In the
contrary, GD virus, which is engineered with limited evolutionary
capacity, is unable to establish similar population compositions to
WT. This is correlated with the IFN-dependent attenuation of
GD in vivo, suggesting that the rapid adaptive capacity of viral
populations is required to overcome early innate immune
responses. Of note, while the observations presented here suggest
a central role of diversity in counteracting innate immunity,
other challenges, such as those imposed by specific cell-type
and physicochemical environments, are expected to be present
during infection.
Our experiments suggest that the diversity and genetic
composition of poliovirus population, and their spatial and
temporal dynamics, are virulence determinants. Viral populations
rapidly and reproducibly adapt to distinct challenges present in
the host environment, thereby locally regulating specific viral
functions in response to selections. Our findings provide
mechanistic insight into the role of the RNA virus population
diversity, subpopulation cooperation, and group selection during
in vivo infection. The maintenance of genetic diversity and
structure in a viral population facilitates successful adaptation by
providing potential solutions to the selective challenges encoun-
tered in distinct environments, tissues or organisms. Adaptive
alleles can only rapidly accumulate with effective recombination
to alleviate the deleterious mutational load. We show, through the
modulation of these parameters, that the balance of mutation and
recombination, is finely tuned and determines the outcome of
infection. These forces are also expected to play an important role
across larger scales as well, such as in host-to-host transmission, a
process central to virus survival.
Acute infection is characterized by rapid evolution to specific
pressures, and our results suggest that tampering with the
adaptive capacity of a virus may provide a means to alter the
outcome of infection. This presents a number of possibilities for
therapeutic strategies and rational vaccine design. A better
understanding of the correlation between population allele
composition and tissue adaptation may allow the design of
viruses with specific host and tissue tropism. Moreover, linking
the population dynamic effects of mutation and recombination
rates to specific viral polymerases may be fundamental for our
understanding of viral infection and dynamics in nature, and may
help to explain why some viruses are more virulent than others,
or how attenuated strains (like the Sabin PV vaccine strain)
evolve to more pathogenic phenotypes.
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Methods
Cells, plasmids and viruses. HeLaS3 cells (ATCC, CCL-2.2), L929 (ATCC,
CCL-1), MG63 (ATCC, CRL-1427), COS7 (ATCC, CRL-1651), L20B cells were
obtained from National Institute for Biological Standards and Control (NIBSC,
United Kingdom) and primary embryo fibroblast cells (MEFs) isolated from 12.5
to13.5 days pregnant Tg21PVR mice. L20B and MEFs were cultured in DMEM
high glucose/F12 medium (UCSF cell culture facility) supplemented with 10%
newborn calf serum (Sigma) and 1xpenicillin/streptomycin/glutamine (100×PSG,
Gibco). The Mahoney strain of poliovirus Type 1 was used as WT virus in this
study. Viral RNA-dependent RNA polymerase (RdRp) mutant viruses (G64S/
D79H (GD)), and 2B mutants (I2V (1032 Ile->Val, nucleotide position, 3836–3838
ATC->GTG), I6V (1036 Ile->Val, nucleotide position, 3848 A->G), I6M (1036 Ile-
>Met, nucleotide position, 3850 A->G)) were modifications from WT Mahoney
type 1 poliovirus (PV) strain. To generate these mutant viruses, T7 polymerase was
used to generate in vitro transcribed (IVT) viral RNA derived from corresponding
linearized prib(+)XpA Mahoney plasmid. The resulting 10 μg IVT RNAs were
electroporated into 8 × 106 HeLaS3 cells. Viruses were harvested at 24 h to generate
P0 virus stocks. P0 stocks were amplified once in HeLaS3 cultured in 2%
serum media approximately m.o.i=10 to generate a passage 1 (P1) stocks. In all
subsequent experiments P1 stocks were used.
Identification of recombination deficient poliovirus. To screen for
recombination-deficient poliovirus, a GFP gene was cloned into the poliovirus
Mahoney genome (GenBank: NC_002058.3) between the structural proteins and
non-structural proteins flanked by 2 A cleavage sites (2A-GFP-2A). The resulting
polio-GFP (PV-GFP) virus was passaged using limited dilution at each passage in
HeLaS3 cells in 96 wells. The GFP retention ratio was measured in plate reader.
A viral clone with reduced recombination was selected based on a high GFP
retention ratio. Sanger sequencing was performed to sequence the viral clone,
a single amino acid mutation, an aspartic acid 79 to histidine (D79H) in
RNA-dependent RNA polymerase (RdRp) was identified. Then, D79H mutation
was cloned back to the poliovirus genome and the GFP retention experiment was
repeated. The result confirmed that D79H confers a viral phenotype deficient
in recombination. The GFP retention rate for D79H was approximately 60%
compared to 10% for WT26.
CRE-REP recombination assay. Two non-viable, (PVcre) and IVT viral RNAs
were used in a previously described recombination assay29 (Fig. 1a). However,
viable progeny can be generated upon recombination between the non-viable
viral RNAs. The first variant of IVT RNA (PVcre) contained a mutation in the
cis-acting replication element (CRE) within the 2 C coding region. This
mutation impairs RNA synthesis and, therefore, does not produce viable progeny.
A second viral RNA lacking capsid proteins (Rep1L) is replication competent but is
unable to produce viable progeny due to the lack of structural proteins. For
homologous recombination, we used type 1 poliovirus Mahoney strain as the
genetic backbone. The synthesis-restricting mutation in PVcre is A4472G (referred
below as PV1cre)37. For non-homologous recombination, we used Sabin 3 strain of
poliovirus, with eight synthesis-restricting synonymous substitutions within CRE
(referred below as S3Bcre)38.
The second variant of IVT RNA is a sub-genomic replicon (Rep1L) where
capsid is replaced with luciferase. Rep1L also does not produce viable progeny on
its own, because it cannot encode capsid. Following co-transfection PV1cre and
Rep1L (or PV1cre and Rep1L containing D79H mutant) into permissive L929 cells,
viable progeny is produced only if recombination of the two defective variant
RNAs takes place between the structural proteins (capsid) and CRE. The same
assay was used for non-homologous recombination, where PV1cre was replaced by
SB3cre. Thus, either 5 μg of each variant RNAs alone or 10 μg of two variants
together were transfected by electroporation into approximately 4 × 106 of
permissive L929 cells. Then, cells were incubated at 37 °C for 24 h. The standard
TCID50 assay was performed to titer the virus stocks.
Virus growth curve and qRT-PCR analysis of viral RNA replication kinetics.
2.5 × 105 L20B cells were seeded in 12-well plates. On the following day, cells were
washed twice with PBS and were infected with virus in 200 μl serum-free media at
m.o.i=0.1 (n= 3, three replicate wells were used for each virus at each time point).
Following a 40 min incubation at 37 °C, each well was washed twice with PBS, and
cells were covered with fresh complete media. At each indicated time point, the
corresponding plate was removed and frozen at −80 °C. Following three freeze-
thaw cycles of the plates, standard plaque assays were performed on monolayer
HeLaS3 cells grown in a 6-wells plate (106 HeLaS3 cells per well). For qRT-PCR
assay, RNA was extracted from 200 μl cell-free viral supernatant for each virus at
each time point (0–12 h) by purelink RNA mini kit (Life Technologies), poliovirus
specific primer (primer-RT) was used to prime cDNA synthesis on 1/4 of
each RNA preparation (4.5 μl) in a 10 µl volume with reverse transcriptase III
(Invitrogen). cDNA were diluted and qPCR primers as described39, and 2 μl of this
diluted cDNA was analyzed by RT-PCR by using 2×Fast Mastermix (KAPA
Biosystems). The cycling condition used were 95 °C for 5 min, 40 cycles of 95 °C for
5 s, and then 60 °C for 30 s40.
Growth competition assays. Monolayer L20B cells (106 cells per well) were
grown in 6-well plates and were infected by equal amounts of two virus
strains with the total m.o.i= 0.01 at a ratio 50%:50%. Cells were infected for 8 h
(Passage 1). The virus stocks were frozen at −80 °C. Following 3 cycles of
freezing and thawing, 1/100th of the volume (20 μl) of passage 1 stocks (2 ml)
were transferred to fresh cells at the next passage (Passage 2). This process was
repeated for the total of four passages. Total RNA was extracted from virus
stocks using Trizol (Ambion). Poliovirus genome-specific primer was used to
prime cDNA synthesis with 1/10th volume (2 μl) of the total RNA by in vitro
transcriptase III (SS III, Invitrogen). RT-PCR was performed by using specific
poliovirus primers. Reactions were subjected to 40 cycles of 95 °C for 30 s, 58°C
for 30 s, 72 °C for 30 s, sanger sequencing the PCR products of passage 1 (P1)
and passage 4 (P4).
Interferon β (IFNβ) production measured by ELISA and qRT-PCR. 2.5 × 105
cells/well MG63 cells were seeded into 12 well plates, overnight. Cells were infected
by WT poliovirus, 2BI2V, 2BI6V or 2BI6M for 40 min at m.o.i=20, then at 5.5 and
7.5 h postinfection, the supernatant was collected to measure interferon production
by ELISA (VeriKine-HS Human Interferon Beta Serum ELISA Kit, PBL Assay
Science). For experiments performed on murine embryos fibroblast cells (MEFs),
cells were isolated from 12.5–13.5 day old embryos. MEF monolayers were seeded
at 2.5 × 105 cells per well in 12-well plates, infected by WT poliovirus, 2BI2V,
2BI6V, or 2BI6M for 40 min at m.o.i=0.1. At 72 h postinfection, supernatant was
collected to measure IFNβ induction by ELISA (VeriKine-HS Murine Interferon
Beta Serum ELISA Kit, PBL Assay Science). Then medium was aspirated and
washed twice with PBS, total RNA was extracted with 200 μl Trizol Reagent
(Ambion) and treated with Dnase1. 1 µg Dnase1-treated RNA was used to syn-
thesize cDNA by iScript cDNA Synthesis kit (Bio-rad). cDNA was quantified by
real-time qRT-PCR by 2×Fast Mastermix (Kapa Biosystems). Sequencing primers
showed as Supplementary Table 2. The thermocycling conditions for IL6, IL8,
TNFα, RIG-I, and β-actin was 95 °C for 5 min, 45 cycles of 95 °C for 5 s, and then
55 °C for 30 s and 72 °C for 20 s; condition for IRF7 and ISG56 was 95 °C for 5 min,
45 cycles of 95 °C for 5 s, and then 58 °C for 30 s and 72 °C for 20 s. The β-actin
gene was used for normalization of murine experiments and GAPDH was used for
human cell experiments. Data were analyzed using the comparative ΔΔCt method
using the following formula: ΔCt=Ct (target)−Ct (normalizer). The comparative
ΔΔCt calculation involved finding the difference between the target (GD, 2B
mutant or WT) ΔCt and the baseline (PBS) ΔCt. Fold changes in the expression of
specific mRNA compared with β-actin or GAPDH was calculated as 2-(ΔΔCt).
Student t-test, n.s. indicates P> 0.05. *P≤ 0.05, **P≤ 0.01, ***P≤ 0.001.
Interferon α response sensitivity assay. Approximately 2.5 × 105 monolayer
HeLaS3 cells were pre-treated with 500 IU/ml of IFN α(Universal type I IFN
alpha, PBL Assay Science) for 24 h, washed twice with PBS, then infected by virus
at m.o.i=0.01 for 40 min. Virus was removed and cells were washed with PBS and
supplemented with fresh medium and incubated at 37 °C for 24 h. Plates were then
frozen at −80 °C. Following 3 freeze and thaw cycles, plaque assays were performed
on HelaS3 cells to quantify virus production.
Inhibition of protein secretion activity. We transfected 50 μg reporter plasmid
carrying EMCV-IRES-driven SEAP reporter into ~5 × 106 monolayer COS7 cells
by Lipofectamine 200034. After 6 h transfection, cells were trypsinized and seed
into 12 wells plate (2.5 × 105 cells per well). On the following day, cells were
infected with poliovirus: WT, 2B I2V, 2B I6V, 2B I6M at m.o.i=10. Media were
collected as indicated time-points. SEAP activity were measured by Great EscAPe
SEAP Chemiluminescence Kit 2.0 Kits (Clontech).
Infection of susceptible mice. We followed protocols approved by the UCSF
Institutional Animal Care and Use Committee for the mouse studies. In these
experiments, 5 to 6-weeks-old Tg21PVR (Tg21) or Tg21 PVR α/β IFN receptor
knockout (IFNAR−/−) both male and female mice were used and infected under
anesthesia. Tg21 and IFNAR−/− were kindly provided by Professor Julie Pfeiffer
of the University of Texas Southwestern Medical Center, and originally were
generated by Dr. Satoshi Koike of Tokyo Metropolitan Institute for Neuroscience.
For mice survival studies, mice were injected by intra-peritoneal injection
(I.P., 100 μl per mouse) or by intra-muscular (I.M., 50 μl of inoculum administered
in each hind leg) with serial dilutions of each virus, respectively (10 mice per
group). Mice were monitored daily for the onset of paralysis and were euthanized
when death was imminent. For tissue distribution studies, we injected Tg21 mice
(5 mice per group) with viral supernatant 106 PFU per mouse by I.P. route, 104
PFU per mouse by I.M. and intra-cranial (I.C.) route, respectively (4 mice per
group). IFNAR−/− mice were inoculated by intra-peritoneal route with 104 PFU per
mouse (5 mice per group). Whole organs were collected from infected mice and
homogenized in 1 ml serum-free media. Viral supernatants were collected from the
tissue homogenates, following three freeze-thaw cycles, and centrifuged at 5000 g
for 10 min in a bench top centrifuge at 4 °C. Regular plaque assays were performed
on HeLaS3 cells to titer viral supernatants from tissues.
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In vivo RNA deep sequencing (RNA-Seq) of host transcriptomes and viral
populations. Five to 6-weeks-old Tg21 mice (three mice per group, per time point)
were infected with mock (PBS) or different doses of WT virus: WTC (106 PFU WT
virus per mouse), WTB (107 PFU WT virus per mouse) or 108 PFU GD. Organs
were collected at one and 3 days postinfection. ~ 100 mg of each organ from
infected Tg21 mice were homogenized in 1 ml Trizol reagent. Total RNA was
extracted, and then treated with DNase1. 10 µg DNase1 treated RNA was purified
by poly-A beads (Bioo scientific). For viral population sequencing, tissues were
homogenized in 1 ml serum-free medium. RNAs were extracted from supernatants
by Zymo-viral RNA extract kit (Zymo Research). The viral RNAs were purified by
poly-A beads (Bioo scientific). RNA-Seq libraries were made using KAPA stranded
RNA-Seq kit (Kapa Biosystems). Viral and host RNA-Seq libraries were sequenced
by Illumina Hiseq 4000.
Pairwise genetic distances between sequenced viral populations were
computed as the Weir-Reynolds distance for all alleles detected by RNA-Seq41.
Multidimensional scaling and visualization of viral sequence and gene expression
trajectories was performed in R with the “cmdscale” function and the “ggplot2”
package. Differential gene and transcript expression analysis of RNA-Seq
experiments with TopHat and Cufflinks42. Host gene expression profiles for
(N= 565) were clustered across all times and conditions using the “ward.D2”
algorithm based on pairwise Euclidian distances between expression profiles.
After dendrogram visualization, 5 clusters were assigned using “cutree” in R.
Sequence diversity was computed as Shannon’s entropy43 using a log base 4, to
scale entropy values between 0 and 1.
CirSeq of poliovirus populations. Each viral population was generated by
infecting 107 monolayer HeLaS3 cells at m.o.i=0.1 for single round replication
cycle 8 h. For IFN treated condition, we pre-treated 107 monolayer HeLaS3 cells
with 10 ml, 1 IU/ml IFNβ (PBL Assay Science) for 14 h, PBS wash twice before
virus infection. We performed seven passages for each virus strain. To amplify each
viral population, 107 monolayer HeLaS3 cells were infected at m.o.i=10. Virus was
harvested after completely cytopathic effect (at postinfection 8 to 9 h). CirSeq
libraries were produced by following the protocol described previously and
sequenced by Illumina HiSeq 250027, 28.
Data analysis and statistical analysis. Data were presented as mean ± s.d.
Statistical analysis was performed using GraphPad Prism (GraphPad Software).
Statistical significance was calculated using a Student’s t-test and p< 0.05 was
considered significant. 50% lethal dose (LD50) was calculated as described by the
Reed and Muench method. Significance is noted with asterisks as described in the
figure legends. Animal experiments were not blinded or randomized, and no
animals or samples were removed as outliers from the analysis.
Fitness calculation of CirSeq data. All CirSeq viral populations sequencing data
was analyzed by the CirSeq V2 pipeline. Sequence diversity was computed as
Shannon’s entropy43 using a log base 4, to scale entropy values between 0 and 1.
For fitness calculations, the deviation from normality in standard deviation (s.d.)
units was computed by Binomial Bayesian regression as described28. The com-
parison of IFN treated and untreated poliovirus populations was performed for
approximated 5 passages as follows: we restored frequencies of the passages 4 and
7 as the averages of the neighboring passages 3, 5 for passage 4 and 6, 8 for passage
7, and then coverage/mutation counts were estimated from frequencies and average
coverages of two neighboring passages for passages 4 and 7. We calculated the
normalized fitness for PV and PV + IFN datasets.
Code availability. Code supporting this analysis has been deposited in the GitHub
repository (https://github.com/ptdolan/Xiaoetal_2017_analysis).
Data availability. Raw deep-sequencing read data have been deposited in the
NCBI BioProject database with accession code PRJNA383905. The authors declare
that all other data supporting the findings of this study are available in the article
and its Supplementary Information files, or from the Stanford Digital Repository
(https://purl.stanford.edu/pc148ks8466).
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